The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma

被引:20
|
作者
Giuliani, Nicola [1 ]
Chiu, Martina [2 ]
Bolzoni, Marina [1 ]
Accardi, Fabrizio [1 ]
Bianchi, Massimiliano G. [2 ]
Toscani, Denise [1 ]
Aversa, Franco [1 ]
Bussolati, Ovidio [2 ]
机构
[1] Univ Parma, Dept Clin & Expt Med, Parma, Italy
[2] Univ Parma, Dept Biomed Biotechnol & Translat Sci, Parma, Italy
关键词
Multiple myeloma; glutamine; metabolism; target therapy; ASCT2; CANCER; CELLS; METABOLISM; GROWTH; TRANSPORTERS; ADDICTION; STRESS; MTORC1;
D O I
10.1080/14728222.2017.1279148
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:231 / 234
页数:4
相关论文
共 50 条
  • [1] DEPENDENCE ON GLUTAMINE ADDICTION AND UPTAKE BY MYELOMA CELLS CHARACTERIZES MULTIPLE MYELOMA PATIENTS AND DELINEATES A NEW ATTRACTIVE THERAPEUTIC TARGET
    Giuliani, N.
    Bolzoni, M.
    Chiu, M.
    Accardi, F.
    Storti, P.
    Airoldi, I.
    Todoerti, K.
    Agnelli, L.
    Costa, F.
    Marchica, V.
    Mancini, C.
    Martella, E.
    Donofrio, G.
    Neri, A.
    Aversa, F.
    Bussolati, O.
    HAEMATOLOGICA, 2016, 101 : S13 - S13
  • [2] Indirubins: A Potential Therapeutic Target in Multiple Myeloma
    Bagratuni, Tina
    Gaboriad-Kolar, Nicolas
    Zakopoulou, Roubini
    Myrianthopoulos, Vassilios
    Kastritis, Efstathios
    Terpos, Evangelos
    Mikros, Emmanuel
    Skaltsounis, Alexios-Leandros
    Dimopoulos, Meletios A.
    BLOOD, 2016, 128 (22)
  • [3] Indirubins: A Potential Therapeutic Target in Multiple Myeloma
    Bagratuni, Tina
    Gaboriad-Kolar, Nicolas
    Zakopoulou, Roubini
    Myrianthopoulos, Vassilios
    Kastritis, Efstathios
    Terpos, Evangelos
    Mikros, Emmanuel
    Skaltsounis, Alexios-Leandros
    Dimopoulos, Meletios Athanasios
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E40 - E41
  • [4] Hedgehog pathway as a potential therapeutic target in multiple myeloma
    Blotta, Simona
    Negri, Joeseph
    Nanjappa, Purushotharna
    Moreau, Anne-Sophie
    Prabhala, Rao
    Shammas, Masood
    Pelluru, Dheeraj
    McMillin, Douglas
    Tai, Yu-Tzu
    Tassone, Pierfrancesco
    Anderson, Kenneth C.
    Mitsiades, Constantine
    Munshi, Nilchil C.
    BLOOD, 2007, 110 (11) : 206A - 207A
  • [5] Nucleotide excision repair is a potential therapeutic target in multiple myeloma
    Szalat, R.
    Samur, M. K.
    Fulciniti, M.
    Lopez, M.
    Nanjappa, P.
    Cleynen, A.
    Wen, K.
    Kumar, S.
    Perini, T.
    Calkins, A. S.
    Reznichenko, E.
    Chauhan, D.
    Tai, Y-T
    Shammas, M. A.
    Anderson, K. C.
    Fermand, J-P
    Arnulf, B.
    Avet-Loiseau, H.
    Lazaro, J-B
    Munshi, N. C.
    LEUKEMIA, 2018, 32 (01) : 111 - 119
  • [6] Nucleotide excision repair is a potential therapeutic target in multiple myeloma
    R Szalat
    M K Samur
    M Fulciniti
    M Lopez
    P Nanjappa
    A Cleynen
    K Wen
    S Kumar
    T Perini
    A S Calkins
    E Reznichenko
    D Chauhan
    Y-T Tai
    M A Shammas
    K C Anderson
    J-P Fermand
    B Arnulf
    H Avet-Loiseau
    J-B Lazaro
    N C Munshi
    Leukemia, 2018, 32 : 111 - 119
  • [7] Increased fatty acid synthase as a potential therapeutic target in multiple myeloma
    Wang, Wei-qin
    Zhao, Xiao-ying
    Wang, Hai-yan
    Liang, Yun
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2008, 9 (06): : 441 - 447
  • [8] CD84: A Potential Novel Therapeutic Target in Multiple Myeloma
    Gunes, Emine Gulsen
    Lewinsky, Hadas
    Viola, Domenico
    Caserta, Enrico
    Rosenzweig, Michael
    Htut, Myo
    Sanchez, James F.
    Buettner, Ralf
    Marcucci, Guido
    Keats, Jonathan J.
    Krishnan, Amrita
    Rosen, Steven T.
    Shachar, Idit
    Pichiorri, Flavia
    BLOOD, 2018, 132
  • [9] Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma
    Bashiri, Hamed
    Tabatabaeian, Hossein
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [10] Investigating the proteasome stress response as a potential therapeutic target in multiple myeloma
    Van Cleave, Cameron
    Chen, Tianzeng
    Ho, Matthew
    Moscvin, Maria
    Czarnecki, Peter
    Bianchi, Giada
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S155 - S156